GeneOne Life Science, Inc. (KRX:011000)
South Korea · Delayed Price · Currency is KRW 2,005.00
-5.00 (-0.25%)
Last updated: Dec 17, 2025, 11:29 AM KST
GeneOne Life Science Market Cap
GeneOne Life Science has a market cap or net worth of 170.83 billion as of December 19, 2025. Its market cap has decreased by -0.24% in one year.
Market Cap
170.83B
Enterprise Value
198.50B
Revenue
30.90B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,005.00
Market Cap Chart
Since August 30, 1995, GeneOne Life Science's market cap has increased from 3.40B to 170.83B, an increase of 4,924.33%. That is a compound annual growth rate of 13.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 170.83B | 1.18% |
| Dec 30, 2024 | 168.84B | -24.04% |
| Dec 28, 2023 | 222.27B | -59.85% |
| Dec 29, 2022 | 553.65B | -55.74% |
| Dec 30, 2021 | 1.25T | 30.16% |
| Dec 30, 2020 | 961.06B | 1,733.31% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.86T |
| Celltrion | 40.61T |
| ALTEOGEN | 22.65T |
| ABL Bio | 10.50T |
| SK Biopharmaceuticals | 10.35T |
| Yuhan | 8.59T |
| LigaChem Biosciences | 6.27T |
| Peptron | 6.18T |